[Neuro-Behçet's disease].
Ota
Toshio
T
Department of Neuropsychiatry, Saitama Medical School.
D000928:Antidepressive Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D016207:Cytokines; D015235:HLA-B Antigens; D059949:HLA-B51 Antigen; D006360:Heat-Shock Proteins; D006801:Humans; D001523:Mental Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D008727:Methotrexate / Q000008:administration & dosage; D008775:Methylprednisolone / Q000008:administration & dosage; D009422:Nervous System Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D018375:Neutrophil Activation; D011379:Prognosis; D020551:Pulse Therapy, Drug
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D016207:Cytokines; D015235:HLA-B Antigens; D059949:HLA-B51 Antigen; D006360:Heat-Shock Proteins; D008775:Methylprednisolone; D008727:Methotrexate